Skip to main content

Sex differences in postsurgical skeletal muscle depletion after donation of living-donor liver transplantation, although minimal, should not be ignored



Donor safety is the top priority in living-donor liver transplantation. Splenic hypertrophy and platelet count decrease after donor surgery are reported to correlate with the extent of hepatectomy, but other aftereffects of donor surgeries are unclear. In this study, we evaluated the surgical effects of donor hepatectomy on skeletal muscle depletion and their potential sex differences.


Among a total of 450 consecutive donor hepatectomies performed from April 2001 through March 2017, 277 donors who completed both preoperative and postoperative (60–119 days postsurgery) evaluation by computed tomography were the subjects of this study. Donors aged 45 years or older were considered elderly donors. Postoperative skeletal muscle depletion was assessed on the basis of the cross-sectional area of the psoas major muscle. Postoperative changes in the spleen volume and platelet count ratios were also analysed to evaluate the effects of major hepatectomy.


The decrease in the postoperative skeletal muscle mass in the overall donor population was slight (99.4 ± 6.3%). Of the 277 donors, 59 (21.3%) exhibited skeletal muscle depletion (i.e., < 95% of the preoperative value). Multivariate analysis revealed that elderly donor (OR:2.30, 95% C.I.: 1.27–4.24) and female donor (OR: 1.94, 95% C.I. 1.04–3.59) were independent risk factors for postoperative skeletal muscle depletion. Stratification of the subjects into four groups by age and sex revealed that the elderly female donor group had significantly less skeletal muscle mass postoperatively compared with the preoperative values (95.6 ± 6.8%), while the other three groups showed no significant decrease. Due to their smaller physical characteristics, right liver donation was significantly more prevalent in the female groups than in the male groups (112/144, 77.8% vs 65/133, 48.9%; p < 0.001). The estimated liver resection rate correlated significantly with the splenic hypertrophy ratio (r = 0.528, p < 0.001) and the extent of the platelet count decrease (r = − 0.314, p < 0.001), but donor age and sex did not affect these parameters.


Elderly female donors have a higher risk of postoperative skeletal muscle depletion. Additionally, female donors are more likely to donate a right liver graft, whose potential subclinical risks include postoperative splenic enlargement and a platelet count decrease.

Peer Review reports


Living-donor liver transplantation (LDLT) is an established treatment for end-stage liver disease or hepatocellular carcinoma with impaired liver function, especially in a country such as Japan where the shortage of deceased donor livers is a serious problem [1]. While LDLT initially began with paediatric liver transplant using the left lateral sector, the indications for LDLT have largely expanded to adult-to-adult liver transplantation using a left liver graft [2] or right liver graft, and the right liver is now the standard graft choice [3].

Donor safety is of the utmost importance in LDLT. For adult-to-adult liver transplantation, a right liver graft is preferred to a left liver graft due to the larger size of the right liver. Further, compared with the left liver, the anatomy of the hepatic hilum in the right liver is easier to divide and reconstruct [4]. It is well documented, however, that, compared with the left liver, procurement of the right liver results in a greater incidence of morbidity and mortality [5, 6], and is more invasive for the donor than the procurement of other graft types. In addition, donor surgeries are associated with serious ethical issues because of the inherent surgical stress and burden for the donors, both during and after donor surgery. Therefore, we [7] and other Japanese centres [8] believe that right liver procurement should not be the first choice as long as a sufficiently sized graft can be obtained with a left liver graft or right lateral sector graft. Few reports, however, provide the overall picture of the actual impact of graft procurement on a donor’s physical status.

Several recent reports have discussed postoperative depletion of skeletal muscle resulting from the surgical stress of LDLT donation [9] and other abdominopelvic surgery [10,11,12] . Others have reported an increase in the spleen volume and a decrease in the platelet count after live liver donation [13,14,15,16]. Therefore, we hypothesized that perioperative changes in such markers could be an indicator of surgical stress in liver donation, and investigated the actual impact of donor surgery with a focus on the postoperative skeletal muscle mass, spleen volume, and platelet count.


Study population

This retrospective study of prospectively collected data was conducted in accordance with the ethical guidelines for clinical studies at the Tokyo University Hospital. A total of 450 consecutive donor hepatectomies for LDLT were performed at the Department of Surgery, Artificial Organ and Transplantation Division, Tokyo University Hospital, from April 2001 through March 2017. All donors had undergone and passed our donor workup protocol, the details of which are described elsewhere [17], and were considered free from any comorbidities. Because the aim of this study was to evaluate the impact of donor surgery on the postoperative skeletal muscle mass, spleen volume, and platelet count, and it is well known that remnant liver regeneration and the recovery of laboratory data reaches a plateau within 3 months after surgery [18], donors who did not complete computed tomography (CT) imaging between postoperative months 2 and 4 were excluded from the study. Age of 45 years or older was defined as a clinically relevant cut-off value for elderly donors in accordance with an earlier study [19].

Donor hepatectomy surgical technique

Our graft selection criteria and the technical details of our LDLT donor hepatectomies are described in previous reports [7, 17, 20, 21]. Basically, the graft should be over 40% of the standard liver volume [7, 17] of the recipient, and the left liver is the first choice when it satisfies the volume requirement. The subjects comprised 152 cases of right liver graft in which the main trunk of the middle hepatic vein (MHV) was preserved in the remnant donor left liver, named a right liver graft (RLG); 25 cases of extended right liver graft (ERLG), which includes the main trunk of the MHV on the graft side; 9 cases of left liver graft (LLG); 77 cases of left liver graft with the caudate lobe (LLG + CL; and 14 cases of right lateral sector graft (RLSG). In RLG procurement, venous tributaries of V5 and V8 in the graft were reconstructed as needed using cryopreserved venous allografts [20]. These graft variations were classified into two types: donors who underwent the RLG or ERLG procurement were categorized as the RL group (n = 177), and donors who underwent the LLG, LLG + CL, or RSLG procurement were categorized as the Non-RL group (n = 100).

The postoperative surgical complications were classified according to the Clavien-Dindo classification [22] and compared.

Analysis of preoperative and postoperative skeletal muscle mass

Skeletal muscle mass was measured on preoperative and postoperative CT images. We used the cross-sectional area of the psoas major muscle as an alternative to the skeletal muscle mass of the whole body in accordance with previous studies [9, 10, 23] The cross-sectional area of the bilateral psoas major muscles was named the total psoas muscle area (TPA, cm2). TPA was derived by measuring in a semi-automated manner the area included in a manual outline of the borders of the bilateral psoas major muscles with attenuation ranging from − 30 to 110 Hounsfield Units (HU) to exclude the vasculature and fatty infiltration at the level of the third lumbar (L3) vertebrae where both transverse processes are clearly visible. The TPA measurement was performed using image analysis software (OsiriX MD, Geneva, Switzerland). The TPA value was subsequently normalized to body size by dividing TPA by the square of body height (m2) [9, 10, 23], and the resulting value was defined as the total psoas index (TPI, cm2/m2). The rate of postoperative skeletal muscle depletion was calculated by dividing the preoperative TPI by the postoperative TPI. Representative preoperative and postoperative images are shown in Fig. 1.

Fig. 1

Representative case of postoperative muscular depletion. The green coloured area indicates the cross-sectional area of the psoas major muscle at the level of the third lumbar vertebrae

Volumetric analysis of the liver and spleen

Preoperative total liver volume (TLV) and spleen volume (SVpre) were measured from CT images obtained for the purpose of preoperative assessment using three-dimensional volume analysis software (SYNAPSE VINCENT, Fujifilm Inc., Tokyo, Japan). The ratio of TLV to SVpre was calculated and defined as the liver/spleen ratio (LS ratio).

The extent of donor hepatectomy was calculated as follows. The actual weight of the graft liver was measured just after the perfusion of ice-cold lactate Ringer solution and subsequent University of Wisconsin cold storage solution in the back-table operation. It is next to impossible to measure actual graft volume, and therefore the actual graft weight was converted to the estimated graft volume (EGV) assuming that a graft weight of 1 g equals a volume of 1 ml. The estimated liver resection rate (ELRR) was calculated according to the following equation:

$$ \mathrm{ELRR}\left(\%\right)=\mathrm{EGV}\times 100/\mathrm{TLV} $$

Postoperative total spleen volume (SVpost) was also measured as described above, and the splenic hypertrophy ratio (SHR) was calculated according to the following equation:

$$ \mathrm{SHR}\left(\%\right)={\mathrm{SV}}_{\mathrm{post}}\times 100/{\mathrm{SV}}_{\mathrm{pre}} $$

Statistical analysis

Continuous valuables are expressed as means and standard deviations, and were compared using Student’s t test. Categorical variables were compared using the chi-square or Fisher’s exact test as appropriate. Logistic regression analysis was used for multivariate analysis to detect independent risk factors for a postoperative skeletal mass decrease, splenic hypertrophy, and platelet depletion. The cut-off values for these parameters were determined by selecting nice, rounded value closest to the quintile or quartile values respectively. Statistical significance was defined as p < 0.05. All statistical analyses were performed using SPSS statistical software (ver25.0 for Windows and Mac; Chicago, IL, USA).


Study population

A total of 277 donors were included in this analysis. Of the 133 male donors and 144 female donors, 85 donors aged 45 or older were categorised as the elderly donor group, and the remaining 192 donors younger than 45 were categorised as the young donor group. Among the 277 donors, 177 were categorised as the RL group and the remaining 100 donors were categorised as the Non-RL group. The relationship of the donor to the recipient was as follows: son or daughter (n = 124), spouse (n = 72), sibling (n = 52), parent (n = 18), and other relation (n = 11).

Perioperative factors of the donor population

Table 1 shows the body profiles, preoperative volumes of the liver and spleen, preoperative laboratory data, intraoperative variables, graft size, and postoperative variables of all donors and sex-segregated comparisons. Fundamental pre-existing sex differences in relation to physical size were detected. Body height, body weight, body mass index, body surface area, and all size-related parameters were significantly higher in men than in women. Preoperative TPA differed significantly between women and men, and this difference remained after adjusting for body size using TPI. TPI was significantly lower in women than in men (4.07 ± 0.99 cm2/m2 vs. 6.50 ± 1.29 cm2/m2). In the male donor group, donor age correlated significantly with TPI [Pearson’s correlation coefficient (r) = − 0.359, p < 0.001], but this correlation was not significant in women (r = − 0.148, p = 0.08) (Fig. 2). Both TLV and SVpre were significantly smaller in women than in men, reflecting their physical characteristics. No significant difference in the LS ratio was detected between women and men.

Table 1 Donor profiles stratified by sex
Fig. 2

The sex-segregated correlation of donor age and the preoperative total psoas index. r: Pearson’s correlation coefficient; TPI: Total psoas index

The preoperative laboratory data were significantly different between women and men. Total bilirubin (T-bil), albumin (Alb), aspartate aminotransferase (AST), alanine aminotransferase (ALT), indocyanine green retention test at 15 min (ICG-R15), creatinine (Cre), and haemoglobin (Hgb) values were significantly higher in men than in women, while the platelet count was significantly higher in women than in men.

The ratio of right liver graft donation, i.e., the RL group, was 112/144 (77.8%) in women and 65/133 (48.9%) in men (p < 0.001). The ELRR was significantly higher in women than in men (49.5 ± 10.2% vs 41.9 ± 11.5%, p < 0.001), reflecting the graft type selection. The actual obtained graft weight, however, was similar between women and men (533 ± 100 g vs 549 ± 131 g, p = 0.29). There was no significant sex difference in the mean operation time or in the amount of blood loss (g/kg body weight).

With regard to donor surgical complications, no donor death or C-D classification grade greater 4a was observed. Six cases of C-D classification grade 3b were observed, all of which required re-laparotomy for postoperative major bile leakage. Rate of grade 3b complication and duration of postoperative hospital stay did not significantly differ between women and men.

Regarding factors associated with the prolonged hospital stay, major pre- and post-operative variables were analysed for the association, which revealed no significant risk factor except for the near significance of the elderly age (Table 2).

Table 2 Comparison of perioperative factors for prolonged postoperative hospital stay

Postoperative skeletal muscle depletion

The distribution of the postoperative ratio of TPI to the preoperative value is shown in the histogram provided in Fig. 3a. The mean postoperative ratio of TPI for all donors was 99.3 ± 6.3%. The cut-off value for defining clinically relevant postoperative skeletal muscle depletion for the logistic regression model to detect risk factors was set as less than 95% of the preoperative TPI. The number of donors below the cut-off value was 59/277 (21.3%).

Fig. 3

Distribution of the postoperative TPI decrease, SHR, and platelet count decrease. Dashed line indicates cut-off value. TPI: Total psoas index; SHR Splenic hypertrophy ratio

Postoperative splenic hypertrophy

A histogram showing the distribution of the SHR of all donors is shown in Fig. 3b. We set the cut-off value for clinically relevant SHR as 140% for the logistic regression model, and 57/277 (20.5%) donors were beyond the cut-off value.

Postoperative platelet count after liver donation

A histogram showing the distribution of the ratio of the postoperative platelet count to the preoperative count of all donors is presented in Fig. 3c. The cut-off value for a significant platelet count decrease was set as 80% for the logistic regression model. The ratio of donors whose values were below the cut-off value was 73/277 (26.4%).

Factors associated with postoperative changes in the skeletal muscle mass, spleen volume, and platelet count

Risk factors that influence the skeletal muscle depletion, splenic hypertrophy, and platelet count decrease were identified on the basis of univariate and multivariate analyses. Nine potential confounding factors were selected: elderly donor (≥ age 45), sex (female), graft type (RL group), high amount of estimated blood loss per body weight (≥10 ml/kg), long postoperative hospital stay (≥20 days), postoperative complication (presence of C-D classification ≥3b), preoperative low platelet count (< 20.0 × 104/μl), preoperative low LS ratio, i.e., relatively large spleen to liver, (< 7.0), and preoperative low serum albumin (< 4.3 g/dl). Table 3 shows the results of the univariate and multivariate logistic regression analyses for a significant TPI decrease (< 95%), splenic hypertrophy (≥140%), and platelet depletion (< 80%). The analysis revealed that female and elderly age were both independent risk factors for postoperative skeletal muscle depletion (OR: 1.94, 95% C.I.:1.04–3.59 and OR: 2.30, 95% C.I. 1.27–4.24, respectively). The graft type, however, did not influence the skeletal muscle mass depletion. Univariate analysis revealed female donor and right liver graft procurement as significant factors for splenic hypertrophy, but multivariate analysis revealed that the actual independent risk factor for postoperative splenic hypertrophy was only a right liver graft (OR:7.30, 95% C.I. 2.76–19.34). Finally, with regard to platelet count decrease, right liver graft was an independent risk factor (OR: 3.24, 95% C.I. 1.69–6.21). The analysis revealed that a preoperatively low platelet count negatively affected the postoperative platelet count. After identifying the risk factors for postoperative skeletal muscle depletion, we compared donors who exhibited postoperative skeletal muscle depletion (< 95% of preoperative value) and those that did not (Table 4). As shown in Table 4, those with postoperative skeletal muscle depletion had a higher donor age and included a higher proportion of women than those who did not show postoperative muscle depletion. The proportion of donors with right liver procurement and the extent of the liver resection did not significantly differ between those with and without postoperative skeletal muscle depletion. The duration of the postoperative hospital stay was significantly longer in those with skeletal muscle depletion. Other factors, however, such as surgical complication greater than C-D classification 3b, splenic hypertrophy, and platelet count decrease, as well as postoperative haemoglobin level and serum albumin level had no significant effect on the postoperative skeletal muscle depletion. Consistent with previous reports, the ELRR significantly positively correlated with the SHR (r = 0.528, p < 0.001) and significantly negatively correlated with the ratio of the platelet count (r = − 0.314, p < 0.001) (Fig. 4).

Table 3 Clinical variables that influences total psoas index, splenic hypertrophy, and platelet count decrease
Table 4 Comparison of preoperative factors and postoperative outcomes between those with or without skeletal muscle depletion
Fig. 4

Correlation of the ELRR between the splenic hypertrophy ratio and postoperative platelet count decrease. r: Pearson’s correlation coefficient; ELRR: Estimated liver resection rate; SHR: Splenic hypertrophy ratio

Comparison of the extent of skeletal muscle depletion between sex and donor age

Preoperative and postoperative TPI were compared by stratifying all donors into four groups by sex and age (Fig. 5). Male donors showed a significant difference in the preoperative TPI between the elderly and young groups, but the postoperative skeletal muscle mass was almost unchanged in both groups. The preoperative and postoperative skeletal muscle mass also did not differ significantly in the young female group. Only the elderly female group showed a significant postoperative decrease in the TPI.

Fig. 5

Change in the preoperative and postoperative TPI stratified by age group and sex. TPI: Total psoas index, Pre: preoperative, Post: postoperative


Ideally, there would be no aftereffects of liver procurement on the living donors because the LDLT donation is totally altruistic procedure, but more than a few physical and mental disadvantages of live liver donation in donors have been reported, both during and after surgery [5, 24, 25]. Unfortunately, there are also several reports of donor death [6, 26, 27]. Besides the operative morbidities and mortalities, transplant clinicians should be aware of even minimal aftereffects of hepatectomy on live donors even though it is subclinical, and live liver donor candidates should be informed of the details of such potential aftereffects. In this aspect, the present results showing the risk of skeletal muscular depletion among aged female donors and the splenic hypertrophy and accompanying platelet decrease after right liver donation will contribute to the future practice of LDLT.

The main aim of our study was to analyse the aftereffects of donor hepatectomies from the point of view of skeletal muscle depletion after donor hepatectomies and sex differences.

The preoperative TPI stratified by age was significantly lower in the male elderly group, but there was no significant difference in the preoperative TPI between young and elderly female groups. On the contrary, with regard to postoperative muscular depletion, only elderly female donors exhibited a significant decrease in skeletal muscle mass compared with the other three groups. Although we did not measure the testosterone or oestrogen levels in our preoperative assessment of the donor candidates, we speculate that the considerable postoperative skeletal muscle depletion observed in the elderly female donor group is due to oestrogen depletion. In general, oestrogen helps to maintain muscle mass in women and oestrogen levels decrease after menopause [28, 29]. In contrast, in men, testosterone is the main sex hormone that contributes to maintain muscle mass [30]. The definition of an elderly donor varies among previous reports, from 35 to 55 years of age [16, 19, 31]. In this study, we set the cut-off point at age 45. As a result, it is likely that mainly postmenopausal female donors would be assigned to the elderly group because the mean age of menopause is reported to be around 50 years of age [32], although we did not collect information about menstrual status in the present cohort.

To the best of our knowledge, this is the first study to analyse the effect of major hepatectomy focusing on skeletal muscle mass and discussing the age and sex differences among LDLT donors. Live donors for organ transplantation are fundamentally healthy because they must pass strict preoperative medical examinations. Our hospital strictly excluded any donor candidate who had history of comorbidities requiring medication or history of malignant diseases [17], therefore, changes in the skeletal muscle mass before and after donor surgery are purely attributable to surgical stress including the effect of hospitalization itself which is associated with reduced caloric intake, lack of exercise, or prolonged bed rest and can lead to decrease in muscle mass [12]. Pre-existing skeletal muscle depletion before surgery, termed sarcopenia, is now widely considered a postoperative risk factor in various surgical procedures. Several reports indicate that a preoperative status of sarcopenia negatively affects the postoperative prognosis of LDLT recipients [33, 34] as well as those undergoing other gastrointestinal or hepato-biliary-pancreatic surgeries [12, 23, 35] In recent years, there are also several studies that have compared changes in the preoperative and postoperative states of the skeletal muscle. Miyake et al. reported that, in addition to preoperative sarcopenia status, skeletal muscle loss greater than 10% after radical cystectomy for urothelial carcinoma of the bladder is associated with shorter overall survival [10]. Otuji et al. reported that postoperative skeletal muscle loss 7 days after major hepatectomy with extrahepatic bile duct resection is associated with postoperative morbidity and mortality [11]. Postoperative accelerated muscle loss after pancreatic resection negatively impacted survival in pancreatic cancer was also reported [12]. The fundamental difference between our report and these studies is that the subjects in the other studies had malignant disease, while our study focused on definitely healthy people, and therefore, our study eliminated the effect of cancer-induced cachexia [36]. In addition, essence of the donor hepatectomy is summarized to simple resection of the liver and it requires no gastrointestinal reconstruction, i.e. alteration of gastrointestinal structures, due to resection of the primary lesion of the malignancies, or postoperative adjuvant chemotherapy [12], that would affect the postoperative nutritional status.

The number of studies that focusing on muscle wasting after LDLT donation is very limited. Matsumoto reported that a bilateral subcostal incision with midline extension (Mercedes incision) for LDLT donation results in significantly greater atrophy of the rectus abdominis muscle compared with a simple midline incision [37]. They concluded that the muscular atrophy following the Mercedes incision is a result of cutting the dominant nerve of the rectus abdominis muscle. In contrast, to eliminate the direct effect of laparotomy, we measured the psoas major muscle because it locates on the dorsal part of the body and was isolated from the surgical site. Furthermore, using the psoas major muscle to evaluate the amount of skeletal muscle mass is an established method presented by several preceding studies [9, 33]. Only one preceding study that addressed the postoperative change of the psoas major muscle of the LDLT donor was reported [9] . This report showed that psoas muscle significantly decreased in both men and women during the first 1 week after surgery and then gradually and fully recovered to preoperative levels 3 months after donor surgery. This result complemented our study in terms of relatively acute postoperative period, such as first 1 week, because we did not investigate routinely postoperative CT in this acute period unless postoperative complication was suspected. In other words, according to this preceding report, the term 3 months is enough to complete almost recovery of the skeletal muscle wasting. And the detectable difference of skeletal muscle depletion 3 months after surgery would reflect the difference of resilience of each individual to donor surgery.

Secondary, our findings revealed that female donor provide right liver graft more often than male donor. Donation of the right liver is associated with a significant postoperative increase in the spleen volume and decrease in the platelet count. These phenomena are also described in several previous reports [13,14,15,16] . Here we confirmed in a relatively larger cohort that the degree of the postoperative splenic hypertrophy and thrombocytopenia correlated with the ELRR. The preceding study concluded that the extent of liver resection rate for donor surgery did not correlate with skeletal muscle depletion both 1 week and 3 months after donor surgery [9], although that study limited the subject to the donor who underwent right liver procurement only, therefore, the range of the liver resection rate is narrower than our study. The right liver procurement, which is essentially larger graft than left liver or right lateral sector graft procurement, was not risk factor for postoperative skeletal muscle depletion 3 months after surgery in our study strengthen the preceding result. Therefore, amount of the remnant liver, in the acceptable range to perform donor surgery safely, i.e. keeping the remnant liver larger than 30% of donor’s preoperative TLV, plays only a minor role to determine the degree of postsurgical skeletal muscle depletion.

Literatures regarding the impact the skeletal muscle depletion after surgery have been scarce. One study reported that the postoperative skeletal muscle depletion is associated with swallowing function after cardiovascular surgery [38]. The subjects of this study was much older patients of cardiovascular diseases who needed aggressive rehabilitation after operation, which makes it difficult to associate with the present study. Moreover, the minimal skeletal depletion among healthy donors is not likely to affect the postoperative conditions of donors. However, present results revealed that elderly female was at a higher risk of postoperative skeletal muscle depletion after operation even among healthy living donor, which might warrant the future studies investigating the possible sequelae of the skeletal muscle depletion after the operation among other populations.

From a clinical standpoint, the level of the change in the skeletal muscle mass 3 months after donor hepatectomy was relatively slight and subclinical and that is also compatible with the proceeding study [9]. And no obvious adverse effects related to skeletal muscle depletion were detected in our population; therefore, LDLT per se is feasible as ever, regardless of age or sex. Our findings, however, provide evidence of a certain amount of surgical stress on the donor and the responsiveness of each donor to these stresses differ from their age and sex. Transplant clinicians should pay careful attention to the personal characteristics of each individual and inform donor candidates of the possibility of future muscular weakness, especially in elderly females. In addition, we should be aware that right liver procurement induces subclinical portal hypertension in the donor, as demonstrated by the splenic hypertrophy and platelet decrease.

Our study has several limitations. First, this was a retrospective study in a single institution, and we excluded a certain number of donors due to the absence of postoperative CT images within the appropriate period. Second, the relation between skeletal muscle depletion and postoperative symptoms on the donor’s quality of life was not assessed and remains unclear. Finally, the observation period of this study was relatively short and aftereffects of hepatectomy on skeletal muscle mass over a longer period of time, i.e. 6 months, 1 year, or longer were not investigated. The possibility of further muscle depletion or the recovery of skeletal muscle mass requires further evaluation with a longer observation time.


In conclusion, transplant surgeons should pay attention to the possibility of skeletal muscular depletion, even at subclinical levels, in aged female donors. In addition, female donors provide a right liver graft significantly more often than male donors because of their relatively smaller physical characteristics, which carries subclinical risks of postoperative splenic hypertrophy and platelet decrease. We hope that these results will facilitate donor selection and be useful for counselling future donor candidates.

Availability of data and materials

The datasets used and analysed during this study are available from the corresponding author upon reasonable request.



Serum albumin level


Alanine aminotransferase


Aspartate aminotransferase


Body mass index


Computed tomography






Estimated liver resection rate


Indocyanine green retention rate at 15 min


Living donor liver transplantation

LS ratio:

Liver/spleen ratio


Platelet count


Splenic hypertrophy ratio


Spleen volume


Total bilirubin


Total liver volume


Total psoas area


Total psoas index


  1. 1.

    Chen C-L, Kabiling CS, Concejero AM. Why does living donor liver transplantation flourish in Asia? Nat Rev Gastroenterol Hepatol. 2013;10:746.

    Article  Google Scholar 

  2. 2.

    Hashikura Y, Makuuchi M, Kawasaki S, Matsunami H, Ikegami T, Nakazawa Y, Kiyosawa K, Ichida T. Successful living-related partial liver transplantation to an adult patient. Lancet. 1994;343(8907):1233–4.

    CAS  Article  Google Scholar 

  3. 3.

    Yamaoka Y, Washida M, Honda K, Tanaka K, Mori K, Shimahara Y, Okamoto S, Ueda M, Hayashi M, Tanaka A, et al. Liver transplantation using a right lobe graft from a living related donor. Transplantation. 1994;57(7):1127–30.

    CAS  Article  Google Scholar 

  4. 4.

    Everson GT, Hoefs JC, Niemann CU, Olthoff KM, Dupuis R, Lauriski S, Herman A, Milne N, Gillespie BW, Goodrich NP, et al. Functional elements associated with hepatic regeneration in living donors after right hepatic lobectomy. Liver Transpl. 2013;19(3):292–304.

    Article  Google Scholar 

  5. 5.

    Lo CM. Complications and long-term outcome of living liver donors: a survey of 1,508 cases in five Asian centers. Transplantation. 2003;75(3 Suppl):S12–5.

    Article  Google Scholar 

  6. 6.

    Cheah YL, Simpson MA, Pomposelli JJ, Pomfret EA. Incidence of death and potentially life-threatening near-miss events in living donor hepatic lobectomy: a world-wide survey. Liver Transpl. 2013;19(5):499–506.

    Article  Google Scholar 

  7. 7.

    Kokudo N, Sugawara Y, Imamura H, Sano K, Makuuchi M. Tailoring the type of donor hepatectomy for adult living donor liver transplantation. Am J Transplant. 2005;5(7):1694–703.

    Article  Google Scholar 

  8. 8.

    Kurihara T, Yoshizumi T, Yoshida Y, Ikegami T, Itoh S, Harimoto N, Ninomiya M, Uchiyama H, Okabe H, Kimura K, et al. Graft selection strategy in adult-to-adult living donor liver transplantation: when both hemiliver grafts meet volumetric criteria. Liver Transpl. 2016;22(7):914–22.

    Article  Google Scholar 

  9. 9.

    Kim YH, Park UJ, Chung HS, Hong SH, Park CS, Choi JH, Choi HJ, Jung JY, Chae MS. Recovery of the psoas muscle index in living donors after a right lobe hepatectomy for liver transplantation: a single-center experience. Transplant Proc. 2019;51(6):1853–60.

    Article  Google Scholar 

  10. 10.

    Miyake M, Morizawa Y, Hori S, Marugami N, Shimada K, Gotoh D, Tatsumi Y, Nakai Y, Inoue T, Anai S, et al. Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder. BMC Cancer. 2017;17(1):237.

    Article  Google Scholar 

  11. 11.

    Otsuji H, Yokoyama Y, Ebata T, Igami T, Sugawara G, Mizuno T, Yamaguchi J, Nagino M. Surgery-related muscle loss and its association with postoperative complications after major hepatectomy with Extrahepatic bile duct resection. World J Surg. 2017;41(2):498–507.

    Article  Google Scholar 

  12. 12.

    Choi MH, Yoon SB, Lee K, Song M, Lee IS, Lee MA, Hong TH, Choi MG. Preoperative sarcopenia and post-operative accelerated muscle loss negatively impact survival after resection of pancreatic cancer. J Cachexia Sarcopenia Muscle. 2018;9(2):326–34.

    Article  Google Scholar 

  13. 13.

    Kim SJ, Na GH, Choi HJ, You Y, Kim DG. Effect of donor right hepatectomy on splenic volume and platelet count for living donor liver transplantation. J Gastrointest Surg. 2013;17(9):1576–83.

    Article  Google Scholar 

  14. 14.

    Ibrahim S, Chen CL, Wang CC, Wang SH, Lin CC, Liu YW, Yang CH, Yong CC, Concejero A, Cheng YF. Liver regeneration and splenic enlargement in donors after living-donor liver transplantation. World J Surg. 2005;29(12):1658–66.

    Article  Google Scholar 

  15. 15.

    Chen TY, Chen CL, Huang TL, Tsang LL, Wang CC, Wang SH, Yang CH, Concejero AM, Cheng YF. Remnant liver regeneration and spleen volume changes after living liver donation: influence of the middle hepatic vein. Clin Transpl. 2006;20(6):725–31.

    Article  Google Scholar 

  16. 16.

    Ishizawa T, Sugawara Y, Hasegawa K, Ikeda M, Tamura S, Makuuchi M. Extent of hepatectomy on splenic hypertrophy and platelet count in live liver donors. Clin Transpl. 2006;20(2):234–8.

    Article  Google Scholar 

  17. 17.

    Akamatsu N, Kokudo N. Living liver donor selection and resection at the University of Tokyo Hospital. Transplant Proc. 2016;48(4):998–1002.

    CAS  Article  Google Scholar 

  18. 18.

    Aoki T, Imamura H, Matsuyama Y, Kishi Y, Kobayashi T, Sugawara Y, Makuuchi M, Kokudo N. Convergence process of volumetric liver regeneration after living-donor hepatectomy. J Gastrointest Surg. 2011;15(9):1594–601.

    Article  Google Scholar 

  19. 19.

    Shah SA, Cattral MS, McGilvray ID, Adcock LD, Gallagher G, Smith R, Lilly LB, Girgrah N, Greig PD, Levy GA, et al. Selective use of older adults in right lobe living donor liver transplantation. Am J Transplant. 2007;7(1):142–50.

    CAS  Article  Google Scholar 

  20. 20.

    Akamatsu N, Sugawara Y, Nagata R, Kaneko J, Aoki T, Sakamoto Y, Hasegawa K, Kokudo N. Adult right living-donor liver transplantation with special reference to reconstruction of the middle hepatic vein. Am J Transplant. 2014;14(12):2777–87.

    CAS  Article  Google Scholar 

  21. 21.

    Shindoh J, Aoki T, Hasegawa K, Beck Y, Sugawara Y, Makuuchi M, Kokudo N. Donor hepatectomy using hanging maneuvers: Tokyo University experiences in 300 donors. Hepatogastroenterology. 2012;59(118):1939–43.

    PubMed  Google Scholar 

  22. 22.

    Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.

    Article  Google Scholar 

  23. 23.

    Peng P, Hyder O, Firoozmand A, Kneuertz P, Schulick RD, Huang D, Makary M, Hirose K, Edil B, Choti MA, et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg. 2012;16(8):1478–86.

    Article  Google Scholar 

  24. 24.

    Togashi J, Sugawara Y, Tamura S, Yamashiki N, Kaneko J, Aoki T, Hasegawa K, Beck Y, Makuuchi M, Kokudo N. Donor quality of life after living donor liver transplantation: a prospective study. J Hepatobiliary Pancreat Sci. 2011;18(2):263–7.

    Article  Google Scholar 

  25. 25.

    Beavers KL, Sandler RS, Shrestha R. Donor morbidity associated with right lobectomy for living donor liver transplantation to adult recipients: a systematic review. Liver Transpl. 2002;8(2):110–7.

    Article  Google Scholar 

  26. 26.

    Akabayashi A, Slingsby BT, Fujita M. The first donor death after living-related liver transplantation in Japan. Transplantation. 2004;77(4):634.

    Article  Google Scholar 

  27. 27.

    Wiederkehr JC, Pereira JC, Ekermann M, Porto F, Kondo W, Nagima I, Amaral W, Camargo CA, Moreira M. Results of 132 hepatectomies for living donor liver transplantation: report of one death. Transplant Proc. 2005;37(2):1079–80.

    CAS  Article  Google Scholar 

  28. 28.

    Ronkainen PH, Kovanen V, Alen M, Pollanen E, Palonen EM, Ankarberg-Lindgren C, Hamalainen E, Turpeinen U, Kujala UM, Puolakka J et al: Postmenopausal hormone replacement therapy modifies skeletal muscle composition and function: a study with monozygotic twin pairs. J Appl Physiol (1985) 2009, 107(1):25–33.

  29. 29.

    Taaffe DR, Newman AB, Haggerty CL, Colbert LH, de Rekeneire N, Visser M, Goodpaster BH, Nevitt MC, Tylavsky FA, Harris TB. Estrogen replacement, muscle composition, and physical function: the health ABC study. Med Sci Sports Exerc. 2005;37(10):1741–7.

    CAS  Article  Google Scholar 

  30. 30.

    Finkelstein JS, Lee H, Burnett-Bowie SA, Pallais JC, Yu EW, Borges LF, Jones BF, Barry CV, Wulczyn KE, Thomas BJ, et al. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013;369(11):1011–22.

    CAS  Article  Google Scholar 

  31. 31.

    Kim SH, Lee EC, Shim JR, Park SJ. Right lobe living donors ages 55 years old and older in liver transplantation. Liver Transpl. 2017;23(10):1305–11.

    Article  Google Scholar 

  32. 32.

    Shi J, Zhang B, Choi JY, Gao YT, Li H, Lu W, Long J, Kang D, Xiang YB, Wen W, et al. Age at menarche and age at natural menopause in east Asian women: a genome-wide association study. Age (Dordr). 2016;38(5–6):513–23.

    Article  Google Scholar 

  33. 33.

    Izumi T, Watanabe J, Tohyama T, Takada Y. Impact of psoas muscle index on short-term outcome after living donor liver transplantation. Turk J Gastroenterol. 2016;27(4):382–8.

    Article  Google Scholar 

  34. 34.

    Kaido T, Ogawa K, Fujimoto Y, Ogura Y, Hata K, Ito T, Tomiyama K, Yagi S, Mori A, Uemoto S. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant. 2013;13(6):1549–56.

    CAS  Article  Google Scholar 

  35. 35.

    Fujikawa H, Araki T, Okita Y, Kondo S, Kawamura M, Hiro J, Toiyama Y, Kobayashi M, Tanaka K, Inoue Y, et al. Impact of sarcopenia on surgical site infection after restorative proctocolectomy for ulcerative colitis. Surg Today. 2017;47(1):92–8.

    Article  Google Scholar 

  36. 36.

    Talbert EE, Cuitino MC, Ladner KJ, Rajasekerea PV, Siebert M, Shakya R, Leone GW, Ostrowski MC, Paleo B, Weisleder N, et al. Modeling human Cancer-induced Cachexia. Cell Rep. 2019;28(6):1612–22 e1614.

    CAS  Article  Google Scholar 

  37. 37.

    Matsumoto K, Noda T, Eguchi H, Iwagami Y, Akita H, Asaoka T, Gotoh K, Kobayashi S, Marubashi S, Umeshita K, et al. Atrophy of the rectus Abdominis after left-side donor hepatectomy: comparison of upper abdominal midline vs Mercedes incision. Transplant Proc. 2019;51(5):1496–501.

    Article  Google Scholar 

  38. 38.

    Wakabayashi H, Takahashi R, Watanabe N, Oritsu H, Shimizu Y. Prevalence of skeletal muscle mass loss and its association with swallowing function after cardiovascular surgery. Nutrition. 2017;38:70–3.

    Article  Google Scholar 

Download references


We thank Junichi Shindoh at the Department of Gastrointestinal Surgery, Toranomon Hospital, for consulting on the study design and statistical analysis, and Yoshifumi Beck at the Department of Hepato-Biliary-Pancreatic Surgery, Saitama Medical Center, for his support in conceptualizing the study.


Not applicable.

Author information




RN collected data, performed the imaging analysis and statistical analysis, and prepared the manuscript. NA directed the study design and critically revised the manuscript. AN supported the data collection. JK, TI, and JA conducted perioperative management of the study subject. KH presided over the study and critically revised the manuscript. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Kiyoshi Hasegawa.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the institutional review board of Tokyo University Hospital (approval number 2158). Written informed consent for surgery and use of their clinical data was obtained from all participants.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nagata, R., Akamatsu, N., Nakazawa, A. et al. Sex differences in postsurgical skeletal muscle depletion after donation of living-donor liver transplantation, although minimal, should not be ignored. BMC Surg 20, 119 (2020).

Download citation


  • Living-donor liver transplantation
  • Psoas major muscle
  • Skeletal muscle depletion
  • Sex difference